Versão BETA

Acesso livre
Acesso livre

Tumores Gastrintestinais

Estudo randomizado: Quimioterapia de intensidade reduzida em pacientes idosos frágeis com câncer gastresofágico avançado propicia uma melhor experiência ao paciente, sem perda significativa no controle da doença.

20 Mai, 2021 | 10:42h

Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer: The GO2 Phase 3 Randomized Clinical Trial – JAMA Oncology

Comentário: Lowering Chemo Dose Achieved Happier Patients, Good Outcomes in Elderly GI Cancer Patients – Physician’s Weekly

 

Comentário no Twitter

 


Resultados de longo prazo em estudo randomizado confirmam os benefícios da quimiorradioterapia neoadjuvante somada à cirurgia para câncer esofágico.

20 Mai, 2021 | 10:41h

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial – Journal of Clinical Oncology

 

Comentários no Twitter

 


Diretriz USPSTF: Iniciar o rastreamento para câncer colorretal aos 45 anos para a maioria dos pacientes.

19 Mai, 2021 | 09:39h

Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement

Relatório de evidências: Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Editoriais: US Preventive Services Task Force Recommendations for Colorectal Cancer Screening: Forty-Five Is the New Fifty – JAMA E Updated USPSTF Guidelines for Colorectal Cancer Screening: The Earlier the Better – JAMA Surgery E Colorectal Cancer Screening Starting at Age 45 Years—Ensuring Benefits Are Realized by All – JAMA Network Open

Estudo: Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force – JAMA

Entrevista com o autor: USPSTF Recommendation: Screening for Colorectal Cancer

Página do paciente JAMA: Screening for Colorectal Cancer


Guia para potencializar a recuperação de pacientes oncológicos submetidos a cirurgia: ERAS para pacientes de cirurgia citorredutora com ou sem quimioterapia hipertérmica intraperitoneal.

19 Mai, 2021 | 09:24h

Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without HIPEC – Annals of Surgical Oncology

Diretrizes relacionadas:

Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS®) Society Recommendations — Part I: Preoperative and intraoperative management

Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced Recovery After Surgery (ERAS®) Society Recommendations — Part II: Postoperative management and special considerations

Ver também: Enhanced Recovery After Surgery (ERAS) Society Guidelines


Revisão atualizada do tratamento para tumores estromais gastrintestinais avançados.

13 Mai, 2021 | 10:01h

An updated review of the treatment landscape for advanced gastrointestinal stromal tumors – Cancer


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.